KeyBanc Starts AngioDynamics (ANGO) at Overweight

KeyBanc initiated coverage on AngioDynamics (NASDAQ: ANGO) with an Overweight rating and a price target of $20. Analyst Matthew Mishan called the company a small cap idea with significant upside if revenue growth can accelerate.

"Ultimately we believe: 1) the bigger picture is better than recent execution; 2) there are multiple potential drivers of revenue growth; 3) should revenue improve, there is a multi-year runway for margin expansion and long-term capital allocation; and 4) at an EV/ Sales of <2x, there is downside support for the stock," said Mishan.

For an analyst ratings summary and ratings history on AngioDynamics click here. For more ratings news on AngioDynamics click here.

Shares of AngioDynamics closed at $15.60 yesterday.

You May Also Be Interested In

• L'Oreal SA (OR:FP) (LRLCY) PT Raised to EUR420 at HSBC
• Solvay SA (SOLB:BB) (SOBS) PT Raised to EUR29 at Stifel
• Church & Dwight Co. Inc. (CHD) PT Raised to $120 at Oppenheimer